Turtle deer glue, epimedium, and rhodiola pills enhance bone mineral density of ovariectomized rats

doi:10.3969/j.issn.2095-4344.2013.15.002

Abstract

Abstract:

BACKGROUND: At present, there are no systematic pharmacodynamic studies addressing osteoporosis
treatment with Chinese medicine. Chinese prescription is not simple enough and research on the mechanism is not close to the guiding of Chinese medicine theory.
OBJECTIVE: To observe the therapeutic effects of turtle deer glue, epimedium, and rhodiola pills on serum indices, bone mineral density and osteoclast regulation in ovariectomized rats.
METHODS: Ovariectomized rats were prepared and subjected to intragastric administration of turtle deer glue, epimedium and rhodiola in comparison with sham-surgery and model groups. The body mass was detected once a week starting from week 4. Bone mineral density, serum calcium, phosphorus content, and blood alkaline phosphatase activity were detected at week 12. Osteoclast inhibiting rates were evaluated by in vitro osteoclast culture model.
RESULTS AND CONCLUSION: The body mass increased for the model group, the turtle deer glue could significantly reduce the increase rate (P < 0.05). After 12 weeks, compared with the model group, the serum calcium content was significantly higher in the three Chinese medicine groups (P < 0.05), whereas the blood phosphorus content and alkaline phosphatase activity were obviously lower (P < 0.05). Bone mineral density in the turtle deer glue and epimedium groups was significantly increased as compared with that in the model group (P < 0.05). The number of resorption pits was decreased significantly in the three Chinese medicine groups, especially in the rhodiola group, as compared with the sham-surgery group (P < 0.05). Rhodiola pills could prohibit the absorptive function of osteoclasts, the inhibitory rate of which was 86.85% (P < 0.01). These findings indicate that turtle deer glue, epimedium, and rhodiola all have significant effects on ovariectomized osteoporosis. Turtle deer glue and epimedium mainly increase bone mineral density, while rhodiola pills prohibit the absorptive function of osteoclasts.

Key words: tissue construction, bone tissue construction, osteoporosis, ovariectomized rats, turtle deer glue, epimedium, rhodiola, serum, bone mineral density, osteoclasts, menopause, blood phosphorus, blood calcium, alkaline phosphatase

CLC Number:

R318

Yang Hao-xia, Yang Yang, Xue Peng, Zhou Fu-yi, Wang Sheng-jun. Turtle deer glue, epimedium, and rhodiola pills enhance bone mineral density of ovariectomized rats[J]. Chinese Journal of Tissue Engineering Research, 2013, 17(15): 2669-2676.

Figures/Tables 4

References

[1] Na J, Xu Y, Ma C. Zhongguo Laonianxue Zazhi. 2011;31(20): 4070-4073.那键,许永,马超,等.老年骨质疏松的分子生物学发病机制[J].中国老年学杂志,2011,31(20):4070-4073.

[2] Ma JL, Gu HY, Yang XD. Zhongguo Quanke Yixue. 2009; (18):1744-1746.马俊岭,郭海英,阳晓东.骨质疏松症的流行病学概况[J].中国全科医学,2009,(18):1744-1746.

[3] Maravic M, Jouaneton B, Vainchtock A, et al. Economic burden of osteoporosis in women: data from the 2008 French hospital database (PMSI). Clin Exp Rheumatol. 2012;30(2): 222-227.

[4] Kuzmanova SI, Solakov PC, Geneva-Popova MG. Adherence to bisphosphonate therapy in postmenopausal osteoporotic women. Folia Med (Plovdiv). 2011;53(3):25-31.

[5] Shao AJ. Zhonghua Yixuehui Disanciguzhisusong he Gukuangyan Jiebing Huiyi Huibian. 2011.晁爱军.原发性骨质疏松症的经济和社会负担[C].中华医学会第三次骨质疏松和骨矿盐疾病中青年学术会议论文汇编,2011.

[6] Yang X. Zhongguoshe Quyishi. 2011;27(38):6.杨玺.骨质疏松症的药物治疗[J].中国社区医师,2011,27(38):6.

[7] Yang Z, Tang DZ, Yang Z. Zhongguo Zhongyi Gushangke Zazhi. 2011;(12):70-72.杨铸,唐德志,杨洲,等.药物治疗骨质疏松症的最新研究进展[J].中国中医骨伤科杂志,2011,(12):70-72.

[8] Liao HL. Dangdai Yixue. 2008;(16):2.廖海浪.雌激素、钙与骨质疏松症[J].当代医学(学术版), 2008, (16):2.

[9] Dong L, Guo LH. Zhongguo Guzhi Shusong Zazhi. 2006;(2): 187-188.董利,郭厉华.雌激素辅以钙剂治疗绝经后骨质疏松症疗效观察[J].中国骨质疏松杂志,2006,(2):187-188.

[10] Lin BG, Chen ZQ, Chen LL. Zhongguo Guzhi Shusong Zazhi. 2006;(5):490-491.林伯庚,陈治卿,陈鹭玲.降钙素对骨质疏松症治疗的临床观察[J].中国骨质疏松杂志,2006,(5):490-491.

[11] Wang YH. Zhongguo Kexue Jishu Daxue Chubanshe. 2004.汪延华.钙、降钙素、维生素D与骨质疏松症[M].合肥:中国科学技术大学出版社,2004.

[12] Beard MK. Bisphosphonate therapy for osteoporosis: combining optimal fracture risk reduction with patient preference. Curr Med Res Opin. 2012;28(1):141-147.

[13] Rhee CW, Lee J, Oh S, et al. Use of bisphosphonate and risk of atrial fibrillation in older women with osteoporosis. Osteoporos Int. 2012;23(1):247-254.

[14] Sewerynek E, Stuss M, The role of i.v.i bandronate administration in osteoporosis therapy. Endokrynol Pol. 2011; 62(1):51-60.

[15] Bao LH, Lin H, Li YJ. Zhongguo Guzhi Shusong Zazhi. 2011; 17(3):232-235.包丽华,林华,李永军,等.伊班膦酸钠和阿仑膦酸钠对绝经后骨质疏松的干预研究[J].中国骨质疏松杂志,2011,17(3): 232-235.

[16] Pillai G, Gieschke R, Goggin T, et al. Population pharmacokinetics of ibandronate in Caucasian and Japanese healthy males and postmenopausal females. Int J Clin Pharmacol Ther. 2006;44(12):655-667.

[17] Rizzoli R. Bisphosphonates treatment in patients with osteoporosis. Ther Umsch. 2012;69(3):173-181.

[18] Tan X, Liu F, Ye Z. Zhongguo Guzhi Shusong Zazhi. 2011; 17(4):359-363.谭新,刘芳,叶竹,等.近五年中医药治疗骨质疏松文献分析[J].中国骨质疏松杂志,2011,17(4):359-363.

[19] Xin Y, Bi HY, Yin LM. Zhongguo Guzhi Shusong Zazhi. 2011; 17(12):1115-1118.邢燕,毕宏焱,尹丽梅,等.中医药治疗骨质疏松症的进展[J].中国骨质疏松杂志,2011,17(12):1115-1118.

[20] Zhao BL,Quan TG, Ma H. Zhongguo Zuzhi Gongcheng Yanjiu yu Linchuang Kangfu. 2011;15(11):1937-1940.赵宝林,权铁刚,马洪.四种药物治疗骨质疏松模型大鼠股骨扭转力学特性对比[J].中国组织工程研究与临床康复,2011,15(11): 1937-1940.

[21] Zhang H, Zhao Y, Xu YF. Zhongyao Yaoli yu Linchuang. 2011; 27(5):76-79.张鹤,赵雨,徐云凤.等.鹿骨胶原蛋白对去卵巢所致骨质疏松大鼠的治疗作用[J].中药药理与临床,2011,27(5):76-79.

[22] Yang J, Mo XM, Li JP. Zhongguo Zhongyi Jichu Yixue Zazhi. 2012;18(2)166-168.杨军,莫新民,李劲平.壮骨止痛方治疗大鼠去卵巢骨质疏松症的蛋白质组学分析[J].中国中医基础医学杂志,2012,18(2): 166-168.

[23] Shen JJ. Neimogu Zhongyiyao. 2012;(3):77-78.沈建军.中药防治骨质疏松症作用机制探讨[J].内蒙古中医药, 2012,(3):77-78.

[24] Zhou LZ, Ma Y. Zhongguo Zuzhi Gongcheng Yanjiu yu Linchuang Kangfu. 2003;(1):74-75.周丽珍,马元.中医通补法治疗原发性骨质疏松症的作用机制研究[J].中国组织工程研究与临床康复,2003,(1):74-75.

[25] Chen XF, Chen SH, Lu GY. Zhongchengyao. 2011;(7): 1130-1134.陈晓飞,陈素红,吕圭源,等.补肾活血方治疗骨质疏松症机制研究及探讨[J].中成药,2011,(7):1130-1134.

[26] Li SP. Zhongguo Zuzhi Gongcheng Yanjiu yu Linchuang Kangfu. 2011;15(20):3767-3770.李素萍.骨质疏松动物模型的研究现状[J].中国组织工程研究与临床康复,2011,15(20):3767-3770.

[27] The Ministry of Science and Technology of the People’s Republic of China. Guidance Suggestions for the Care and Use of Laboratory Animals. 2006-09-30.

[28] Liu SP, Liao EY, Wu HW. Hunan Yike Daxue Xuebao. 2001; (2):111-115.刘石平,廖二元,伍汉文,等.绝经后骨质疏松大鼠模型的综合评价[J].湖南医科大学学报,2001,(2):111-115.

[29] Long T, Zhu ZA. Shengwu Guoke Cailiao yu Linchuang Yanjiu. 2009;(4):20-23.龙腾,朱振安.绝经后妇女体脂、瘦体质量与骨密度的相关性[J].生物骨科材料与临床研究,2009,(4):20-23.

[30] Liu ZH. Beijing: Huaxue Gongye Chubaishe. 1992.刘忠厚.骨质疏松症[M].北京:化学工业出版社,1992.

[31] Zhu XL. Tianjin: Tianjin Keji Chubanshe. 1982.朱宪彝.代谢性骨病学[M].天津:天津科技出版社,1982.

[32] Yang XZ, Chen XL, Wang DC. Zhongguo Zuzhi Gongcheng Yanjiu yu Linchuang Kangfu. 2007;(49):9980-9983.杨希重,陈晓亮,王德春.番茄红素与成骨细胞、破骨细胞及骨质疏松症[J].中国组织工程研究与临床康复,2007,(49): 9980-9983.

[33] Ma HP, Yang YJ, Jia ZP. Lanzou Yixueyuan Xuebao. 2001; 27(4):69-70.马慧萍,杨永建,贾正平.淫羊藿防治骨质疏松症的研究进展[J].兰州医学院学报,2001,27(4):69-70.

[34] Xiu CY, Cai H, Guo JH. Anhui Zhongyi Xueyuan Xuebao. 2004;23(6):57-59.修春英,蔡辉,郭郡浩.淫羊藿防治骨质疏松症的研究进展[J].安徽中医学院学报,2004,23(6):57-59.

[35] Dong YF. Zhongyaocai. 2004;27(8):620-622.董远芳.淫羊藿等中药治疗骨质疏松症的临床观察[J].中药材, 2004, 27(8):620-622.

[36] Yang WA. Fujian Zhongyiyao. 2005;(5):19.杨伟岸.龟鹿二仙汤加味治疗老年脊椎骨质疏松性腰背部疼痛63例[J].福建中医药,2005,(5):19.

[37] Zhou XD. Shanghai zhongyiyao zazhi. 2001;35(11):24-24.周修道.“龟鹿二仙汤”为主治疗骨质疏松症临床观察[J].上海中医药杂志,2001,35(11):24-24.

[38] Liu JM, Ge BF, Bai MH, et al. Zhongguo Linchuang Kangfu. 2004;8(27):5910-5912.刘剑梅,葛宝丰,白孟海,等.红景天壮骨丸治疗骨质疏松症的实验研究[J].中国临床康复,2004,8(27):5910-5912.

[39] Bai MH, Ge BF, Zhao XP, et al. Xibei Guofang Yixue Zazhi. 2006;27(6):414-417.白孟海,葛宝丰,赵新平,等.高原对去势大鼠骨密度、生物力学和骨组织学的影响及复方红景天对其保护作用[J].西北国防医学杂志,2006,27(6):414-417.